Q3 2025 ASP Isotopes Inc Earnings Call Transcript
Key Points
- ASP Isotopes Inc (ASPI) successfully shipped commercial samples of silicon-28, which have been validated for isotopic purity by customers.
- The company secured another silicon-28 contract and plans to satisfy all current customer orders by 2026.
- ASP Isotopes Inc (ASPI) has made significant progress in its semiconductor gas vertical, including the acquisition of germanium and nearing completion of Phase 1c.
- The company has started production at its first quantum enrichment plant, producing ytterbium-176, with commercial quantities expected in the first half of 2026.
- ASP Isotopes Inc (ASPI) has expanded its radiopharmaceutical operations, including the commissioning of equipment in South Africa and the acquisition of a radio pharmacy in Florida.
- There have been delays in shipping silicon-28 due to the complexity of starting up a nuclear engineering plant.
- Operating expenses increased by 84% year-over-year, driven by a 66% increase in headcount and higher professional fees.
- The company reported a net loss from operations of $34.9 million for the year-to-date 2025, compared to $18.7 million in 2024.
- ASP Isotopes Inc (ASPI) faced delays in feedstock delivery for its carbon-14 production, impacting timelines.
- Revenue recognition in the isotopes enrichment segment is still pending, with initial commercial batches expected by the end of the year.
Greetings. Welcome to the ASP Isotopes Investor Update Call. At this time, all participants are in a listen-only mode. Please note that this conference is being recorded. (Operator Instructions)
Before we get started, please note that our remarks today may include four looking statements. These statements are subject to risks and uncertainties, and after results may differ materially. During this call, we may use words like anticipate, could, enable, estimate, intend, expect, believe, potential, will, should, project, and similar expressions, which indicate four looking statements. For a more comprehensive discussion of these and other risks, please refer to our filings with the SEC available on SEC.gov and in the investors section of our website.
I'll now turn the call over to CEO Robert Ainscow.
(),- -
Good morning, everybody, and welcome to ASP Isotopes
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
